Treatment Gap in Very High-Risk Patients with Cardiorenal Disease: An Analysis of the Implementation of Evidence-Based Therapies
Background: In patients with type 2 diabetes mellitus (T2DM) and cardiorenal disease, various therapies reduce cardiovascular and renal events. However, their implementation in clinical practice remains suboptimal. Objective: To quantify the treatment gap in patients with T2DM and very high-risk cardiorenal disease usi...